Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · IEX Real-Time Price · USD
0.532
-0.013 (-2.39%)
At close: Apr 25, 2024, 4:00 PM
0.510
-0.022 (-4.12%)
After-hours: Apr 25, 2024, 7:53 PM EDT

BCLI Statistics

Total Valuation

BCLI has a market cap or net worth of $36.36 million. The enterprise value is $36.33 million.

Market Cap 36.36M
Enterprise Value 36.33M

Important Dates

The next estimated earnings date is Monday, May 13, 2024, before market open.

Earnings Date May 13, 2024
Ex-Dividend Date n/a

Share Statistics

BCLI has 68.34 million shares outstanding. The number of shares has increased by 17.99% in one year.

Shares Outstanding 68.34M
Shares Change (YoY) +17.99%
Shares Change (QoQ) +16.46%
Owned by Insiders (%) 13.16%
Owned by Institutions (%) 5.99%
Float 61.06M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.24

Current Ratio 0.24
Quick Ratio 0.17
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -37.46

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -292.50%
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$592,828
Employee Count 29
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -80.86% in the last 52 weeks. The beta is 0.29, so BCLI's price volatility has been lower than the market average.

Beta (1Y) 0.29
52-Week Price Change -80.86%
50-Day Moving Average 0.47
200-Day Moving Average 0.64
Relative Strength Index (RSI) 49.00
Average Volume (30 Days) 1,014,893

Short Selling Information

The latest short interest is 1.99 million, so 2.91% of the outstanding shares have been sold short.

Short Interest 1.99M
Short Previous Month 1.34M
Short % of Shares Out 2.91%
Short % of Float 3.26%
Short Ratio (days to cover) 1.19

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -21.44M
Pretax Income -17.19M
Net Income -17.19M
EBITDA -16.48M
EBIT -16.75M
Earnings Per Share (EPS) -$0.40
Full Income Statement

Balance Sheet

The company has $1.30 million in cash and $1.28 million in debt, giving a net cash position of $25,000 or $0.00 per share.

Cash & Cash Equivalents 1.30M
Total Debt 1.28M
Net Cash 25,000
Net Cash Per Share $0.00
Equity / Book Value -4.86M
Book Value Per Share -0.07
Working Capital -5.90M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$20.46 million and capital expenditures -$18,000, giving a free cash flow of -$20.48 million.

Operating Cash Flow -20.46M
Capital Expenditures -18,000
Free Cash Flow -20.48M
FCF Per Share -$0.48
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BCLI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -17.99%
Shareholder Yield -17.99%
Earnings Yield -47.29%
FCF Yield -56.32%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Hold
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on September 16, 2014. It was a reverse split with a ratio of 1:15.

Last Split Date Sep 16, 2014
Split Type Reverse
Split Ratio 1:15

Scores

Altman Z-Score n/a
Piotroski F-Score 1